Lyme disease, the most common tick-borne infec tion in Canada and much of the United States, is caused by the bacteria Borrelia burgdorferi. Peak incidence for Lyme disease is among children five to nine years of age and older adults (55 to 59 years of age). The bacteria are transmitted through the bite of infected black-legged ticks of the Ixodes species. The primary hosts of black-legged ticks are mice and other rodents, small mammals, birds (which are reservoirs for B burgdorferi) and whitetailed deer. Geographical distribution of Ixodes ticks is expanding in Canada and an increasing number of cases of Lyme disease are being reported. The present practice point reviews the epidemiology, clinical presentation, diagnosis, management and prevention of Lyme disease, with a focus on chil dren.
Peak incidence for LD is among children five to nine years of age and older adults (55 to 59 years of age), and many cases likely go unreported. [1] No relationship between treated maternal LD and abnormal pregnan cies or disease in infants has been documented. [3] Al though there is a theoretical risk, no case of infection has been linked to blood transfusion. [4] Ticks cannot jump or fly. Instead, they climb and wait on tall grasses or shrubs for a potential host to brush against them. They then transfer to the host and seek an attachment site. [5] Immature ticks (nymphs) are re sponsible for most human LD infections because their very small size hinders detection. [1] If a tick is found attached to or feeding on a child, re move it as soon as possible. Ticks can attach and feed for five days or longer (Figure 2 ). Removing a tick with in 24 h to 36 h of its starting to feed is likely to prevent LD. [6] 
How prevalent is LD in Canada?
Black-legged tick populations are well established in parts of British Columbia, Manitoba, Ontario, Quebec, New Brunswick and Nova Scotia, and may be expand ing. Migratory birds can bring infected ticks into nonen demic areas, and people may also become infected while travelling to other endemic areas in North Ameri ca and Europe. [6] In 2009, LD became a nationally re portable disease. The number of reported cases has increased from 128 in 2009 to an estimated ≥500 in 2013. [1] [7] What are the clinical manifestations of LD?
Clinical manifestations are divided into early localized, early disseminated and late disease.
Early localized disease: Erythema migrans (EM) -a rash at the site of a recent tick bite -is the most com mon presentation in children and adults (Figures 3 and  4) . [4] [8] EM typically develops seven to 14 days (range three to 30 days) after a tick bite. EM begins as an ery thematous macule or papule that rapidly expands cen trifugally, sometimes with central clearing. [4] The le sions may be round or oval, flat or slightly raised, and are typically ≥5 cm in diameter. EM is usually painless and not pruritic. However, fever, malaise, headache, mild neck stiffness, myalgia and arthralgia often ac company EM. [1] [4] Early LD can occur without rash, and rash may not be detected by all patients in which it occurs. Without treatment, EM resolves spontaneously over a fourweek period, on average.
Early disseminated disease:
Approximately 20% of children with LD first present to a health care provider with multiple, rather than single, EM lesions. This rash usually occurs several weeks after the tick bite and consists of secondary annular, erythematous lesions similar to but typically smaller than the primary lesion. These lesions reflect spirochetemia with cutaneous dissemination. [4] Other manifestations of early disseminated disease (with or without rash) include acute neurological signs, such as facial nerve palsy, papilledema and lympho cytic meningitis. [4] [9] Children with facial palsy should be assessed for meningitis, especially if neck stiffness or severe headache occurs. [9] [10] [11] Lyme carditis, re sulting in heart block, is rare in children. [4] Late disease: Children treated with antimicrobial agents in the early stage of LD very rarely develop late disease. [4] The most common late-stage symptoms are pauciarticular arthritis affecting large joints, especially the knees, which may manifest weeks to months (mean four months) after the tick bite. Arthritis can oc cur without a history of earlier stages of illness. Periph eral neuropathy and central nervous system manifes tations can also occur, although rarely during late dis ease in children. [4] 
How is the diagnosis of LD made?
Early localized disease: In general, the diagnosis of LD is principally clinical, supported by a history of po tential tick exposure in an area where it is known or suspected that black-legged ticks have been estab lished. However, because tick populations are expand ing, it is possible that LD can be acquired outside of currently identified areas. Such a possibility should be considered when assessing patients. Patients with clear symptoms of early LD should be diagnosed and treated without laboratory confirmation, [1] [4][10] [11] be cause antibodies against B burgdorferi are often not detectable by serodiagnostic testing within the first four weeks after infection. [4] [12] [13] All clinical manifestations of possible LD, except EM, require laboratory confir mation. [13] Early disseminated and late disease: Two-tiered serological testing, including an ELISA screening test followed by a confirmatory Western blot test is used to supplement clinical suspicion of disseminated or late LD ( Figure 5 ). Two-tiered testing is necessary because the ELISA may yield false-positive results from anti bodies directed against other spirochetes, viral infec tions or autoimmune diseases. [1] Table 1 provides in formation related to the performance characteristics of serological assays in different clinical presentations of LD. [6] [14] Supplemental tests can detect Borrelia species that cause LD outside of North America. Therefore, travel history should be documented. [1] Some individuals treated with antimicrobials for early LD never develop antibodies against B burgdorferi. They are cured. [4] [13] Most individuals with early disseminated disease and almost all individuals with late disease have antibodies against B burgdorferi. Once such antibodies develop, they persist for years. A decline in antibody levels is not useful to assess treatment response. [1] [3] Serologi cal test results for LD should be interpreted along with careful consideration of the clinical setting and quality of the testing laboratory. [1] [15] Tests of joint fluid for anti body to B burgdorferi and urinary antigen detection have no role in diagnosis. [3] In suspected Lyme menin gitis, testing for intrathecal immunoglobulin M or im munoglobulin G antibodies may be helpful. [ Reproduced from reference 14 with permission from the American Society for Microbiology. *Sera obtained after antibiotic treatment; percent reactivity refers to the frequency that the different serological assays will be positive depending of the stage of the Lyme disease infection. EM Erythema migrans; Ig Im munoglobulin; WB Western blot (Tables 2 and 3) . [4] Arthritis frequency has decreased in the United States, probably because of improved recognition and earlier treatment of patients with early LD. Up to onethird of LD patients with arthritis experience residual synovitis and joint swelling, which almost always re solve without repeating the antibiotic course. For pa tients who have persistent or recurrent joint swelling after a recommended course of oral antibiotic therapy, some experts recommend retreatment with another four-week course of oral antibiotics or with a course of parenteral ceftriaxone. [10] For cases with ongoing arthritis, consultation with an expert is recommended. [4] Consider hospitalization and constant monitoring for a child with heart block and syncope that may rapidly worsen enough to require a pacemaker. [10] The Jarisch-Herxheimer reaction (fever, headache, myalgia and an aggravated clinical picture lasting <24 h) can occur when therapy is initiated. Nonsteroidal anti-inflammatory agents should be started and the an timicrobial agent continued. [4] Approximately 10% to 20% of cases experience linger ing symptoms of fatigue and joint and muscle aching that last longer than six months. The clinical term for this condition is 'posttreatment Lyme disease syndrome' (PTLDS). [17] The exact cause of PTLDS is not yet known. Most medical experts believe that lin gering symptoms are the result of residual damage to tissues and the immune system. [ 
How to remove a tick
• Use fine-tipped tweezers to grasp the tick close to the skin surface ( Figure 6A ).
• Pull upward with steady, even pressure ( Figure  6B ). Try not to twist or jerk, which can cause the mouthpart of the tick to break off and remain in the skin. If this happens and you are unable to remove the mouthpart easily with clean tweezers, leave it alone and let the skin heal.
• Clean the bite area and your hands with rubbing al cohol, an iodine scrub, or soap and water. [21] The Public Health Agency of Canada advises people to:
• Keep any ticks they remove themselves in a reseal able plastic bag or pill vial and note the location and date of the bite.
• Watch for symptoms and see a health care profes sional immediately should symptoms appear.
• Take the tick with them to their medical appoint ment, to verify species and test as needed. [1] How can LD be prevented?
Physicians should be aware of the epidemiology of tick-borne LD in their area, [1] [2] [7] and recommend some basic precautions for families living, hiking or camping in rural or wooded areas where they may be exposed to ticks. [1] [2] [3] • Where play spaces adjoin wooded areas, land scaping can reduce contact with ticks. [3] A pic togram from the Centers for Disease Control and Prevention is available at: http://www.cdc.gov/lyme/ prev/in_the_yard.html.
• Apply 20% to 30% DEET or icaridin repellents. Re pellents can be applied to clothing as well as to ex posed skin. Always read and follow label directions. [1] [20]
• Do a 'full body' check every day for ticks. Promptly remove ticks found on yourself, children and pets. Shower or bathe within two hours of being outdoors to wash off unattached ticks. [1] For more information on how to prevent tick bites, refer to a recent practice point from the Canadian Paediatric Society at: http://www.cps.ca/en/documents/position/ preventing-mosquito-and-tick-bites.
Postexposure antibiotic therapy
Consensus on postexposure prophylaxis for LD is lacking at this time. Some experts recommend giving doxycycline as a single dose of 200 mg for children and youth ≥8 years of age after a tick bite (for individu als weighing <45 kg, 4 mg/kg to a maximum of 200 mg). Prophylaxis can be started within 72 h of remov ing a tick, even if it has been attached for ≥36 h. [1] [4] [7] [10] Data are insufficient to recommend amoxicillin pro phylaxis in younger children. [1] [4][10] [11] In Canada, such prophylaxis should be considered in 'known endemic areas' (see Table 1 and Figure 1 in reference 1). Physicians should bear in mind that the true prevalence of B burgdorferi is often unknown and that the geographical range of infected ticks is expand ing in some areas. [1] The Public Health Agency of Canada continues to monitor the distribution and prevalence of infected ticks as well as cases of LD. [1] [7] A vaccine to prevent LD in humans is not available at the present time. [1] [4]
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